The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study TTC-352-101: Phase 1 study of TTC-352 in patients with metastatic breast cancer (BC) progressing on endocrine therapy.
 
Ruth O'Regan
Honoraria - bioTheranostics; Pfizer
Consulting or Advisory Role - Astellas Pharma; Atossa Genetics; bioTheranostics; Genomic Health; Lilly; Pfizer; Puma Biotechnology
Research Funding - Cascadian Therapeutics; Eisai (Inst); Novartis (Inst); Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Lilly
Other Relationship - Genomic Health
 
Randolph Hurley
No Relationships to Disclose
 
Jasgit C. Sachdev
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Celgene
 
Debra A. Tonetti
Leadership - TTC Oncology
Stock and Other Ownership Interests - TTC Oncology
Research Funding - G1 Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - G1 Therapeutics License Agreement (Inst); TTC Oncology (Inst)
 
Gregory R. Thatcher
Leadership - TTC Oncology
Stock and Other Ownership Interests - TTC Oncology
 
Robert P Venuti
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Johnson & Johnson; Sarepta Therapeutics
 
Arkadiusz Z. Dudek
Employment - Adhaere Pharmaceuticals
Leadership - IGF Oncology; Martell diagnostic
Stock and Other Ownership Interests - Biothera; IGF Oncology; Vanquish Oncology
Honoraria - Biothera; IGF Oncology; Medtronic; Vanquish Oncology
Consulting or Advisory Role - Biothera; TTC Oncology; Vanquish Oncology